• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Onconephrology: evolving concepts and challenges.

作者信息

Passos Rogerio, Zawadzki Bruno, Macedo Etienne, Durão Marcelino, Coelho Fernanda Oliveira

机构信息

Medical Service Board, Davita Tratamento Renal, Rio de Janeiro, Brazil.

Intensive Care Medicine Department, Albert Einstein Israelite Hospital, São Paulo, São Paulo, Brazil.

出版信息

Front Nephrol. 2025 Apr 4;5:1585605. doi: 10.3389/fneph.2025.1585605. eCollection 2025.

DOI:10.3389/fneph.2025.1585605
PMID:40255462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12006101/
Abstract
摘要

相似文献

1
Editorial: Onconephrology: evolving concepts and challenges.社论：肿瘤肾脏病学：不断演变的概念与挑战
Front Nephrol. 2025 Apr 4;5:1585605. doi: 10.3389/fneph.2025.1585605. eCollection 2025.
2
Onconephrology: Core Curriculum 2023.《Onconephrology：2023 核心课程》
Am J Kidney Dis. 2023 Dec;82(6):743-761. doi: 10.1053/j.ajkd.2023.04.014. Epub 2023 Oct 17.
3
Perspectives From an Onconephrology Interest Group: Conference Report.肿瘤肾脏病学兴趣小组观点：会议报告
Can J Kidney Health Dis. 2020 Oct 15;7:2054358120962589. doi: 10.1177/2054358120962589. eCollection 2020.
4
Is It Time to Integrate Frailty Assessment in Onconephrology?是时候将衰弱评估纳入肿瘤肾脏病学了吗？
Cancers (Basel). 2023 Mar 8;15(6):1674. doi: 10.3390/cancers15061674.
5
Onconephrology: The intersections between the kidney and cancer.肿瘤肾脏病学：肾脏与癌症的交集。
CA Cancer J Clin. 2021 Jan;71(1):47-77. doi: 10.3322/caac.21636. Epub 2020 Aug 27.
6
Knowledge mapping and visualized analysis of research progress in onconephrology: a bibliometric analysis.肿瘤肾脏病学研究进展的知识图谱与可视化分析：一项文献计量分析
Ren Fail. 2025 Dec;47(1):2477302. doi: 10.1080/0886022X.2025.2477302. Epub 2025 Mar 18.
7
Onconephrology: mitigation of renal injury in chemotherapy administration.肿瘤肾脏病学：减轻化疗药物治疗中的肾损伤。
Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):257-266. doi: 10.1097/MNH.0000000000000960. Epub 2023 Dec 14.
8
Onconephrology: Update in Anticancer Drug-Related Nephrotoxicity.肿瘤肾脏病学：抗癌药物相关肾毒性的最新进展
Nephron. 2023;147(2):65-77. doi: 10.1159/000525029. Epub 2022 Jun 17.
9
[Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment].[具有肾脏意义的单克隆丙种球蛋白病：俄罗斯血液学家和肾脏病学家关于疾病分类学的确立、诊断方法及克隆特异性治疗依据的共识]
Ter Arkh. 2020 Sep 1;92(7):10-22. doi: 10.26442/00403660.2020.07.000659.
10
Renal involvement in solid cancers: epidemiological, clinical and histological characteristics study of 154 onconephrology patients.实体瘤相关性肾损害：154 例肿瘤肾脏病患者的流行病学、临床和组织学特征研究。
BMC Nephrol. 2024 Oct 19;25(1):367. doi: 10.1186/s12882-024-03812-7.

本文引用的文献

1
Onconephrology Fellowship Training: Current Status and Future Outlook.肿瘤肾脏病学专科医师培训：现状与未来展望。
Kidney360. 2024 Sep 1;5(9):1380-1385. doi: 10.34067/KID.0000000000000495.
2
Kidney care in patients with cancer: perspectives from the onconephrology committee of the Brazilian Society of Nephrology.癌症患者的肾脏护理：来自巴西肾脏病学会肿瘤肾脏病学委员会的观点
Rev Assoc Med Bras (1992). 2024 Jun 7;70(suppl 1):e2024S121. doi: 10.1590/1806-9282.2024S121. eCollection 2024.
3
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge.免疫检查点抑制剂相关肾毒性：临床病理特征、非侵入性方法、治疗策略及再次挑战方面的进展
Front Nephrol. 2022 Oct 19;2:1017921. doi: 10.3389/fneph.2022.1017921. eCollection 2022.
4
Challenges for optimal care in onconephrology.肿瘤肾脏病学最佳治疗面临的挑战。
Nephrol Dial Transplant. 2024 Jan 31;39(2):167-169. doi: 10.1093/ndt/gfad160.
5
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.常见慢性肾脏病早期治疗的临床试验考虑因素：美国国家肾脏基金会和美国食品药品监督管理局共同主办的科学研讨会。
Am J Kidney Dis. 2022 Oct;80(4):513-526. doi: 10.1053/j.ajkd.2022.03.011. Epub 2022 Aug 13.
6
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.精准医学：肾癌患者护理的最佳方法
Front Med (Lausanne). 2022 Jun 14;9:766869. doi: 10.3389/fmed.2022.766869. eCollection 2022.
7
Nephrotoxicity From Molecularly Targeted Chemotherapeutic Agents.分子靶向化疗药物的肾毒性。
Adv Chronic Kidney Dis. 2021 Sep;28(5):415-428.e1. doi: 10.1053/j.ackd.2021.09.003.
8
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程，无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
9
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer.KDIGO肿瘤肾脏病学争议会议：了解肾功能损害与实体器官恶性肿瘤，以及肾癌的管理
Kidney Int. 2020 Nov;98(5):1108-1119. doi: 10.1016/j.kint.2020.06.046.
10
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.第三个千年之交癌症药物治疗的进展
Front Pharmacol. 2018 Nov 13;9:1300. doi: 10.3389/fphar.2018.01300. eCollection 2018.